MoneyWorks4Me

Suven Life Sciences to spend about Rs 60 crore on R&D in FY15

23 May 2014 Evaluate

Suven Life Sciences is contemplating to spend about Rs 60 crore on R&D in FY15. As of 2014 and 2015 the company expects Rs 400-450 crore on the topline and about Rs 80-90 crore on the bottomline.

Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies through the use of GPCR targets. 

Peers
Company Name CMP
Sun Pharma. Inds. 1857.45
Dr. Reddys Labs. 1150.80
Cipla 1355.70
Lupin 2052.35
Zydus Lifesciences 1107.95
View more..